Aptose Biosciences Inc (APS_TSE) earnings

Quarterly and annual APS_TSE reports and results, each read against the price at its own news timestamp. Back to the APS_TSE overview →

11 measured APS_TSE earnings events.

DateHeadlineEvent5-minTo close
Aptose Reports First Quarter 2026 ResultsPress release——
Aptose Reports Second Quarter 2025 ResultsPress release——
Form 10-Q Aptose Biosciences Inc. For: Jun 30SEC filing · Form 10-Q——
Aptose Reports First Quarter 2025 ResultsPress release——
Form 10-Q Aptose Biosciences Inc. For: Mar 31SEC filing · Form 10-Q——
Aptose Reports Results for the Third Quarter 2024Press release——
Aptose Reports Results for the Second Quarter 2024Press release+0.00%-7.79%
Aptose Reports Results for the First Quarter 2024Press release+0.00%-2.98%
Aptose to Report First Quarter 2024 Financial Results and Provide Clinical Strategy Update on Tuesday, May 14, 2024Press release+0.59%+1.19%
Aptose Reports Results for the Third Quarter 2023Press release+0.00%-15.00%
Aptose to Report Third Quarter 2023 Financial Results and Hold Conference Call on Thursday, November 9, 2023Press release+0.00%+11.46%
Get an email when APS_TSE moves on news →
Keep exploring

More APS_TSE: analyst actions → · SEC filings → · APS_TSE overview →

Other Healthcare names and their earnings

TickerEventsMedian 30-min% positive
EVOFEM BIOSCIENCE INC (EVFM)1110.00%29%
Synlogic, Inc. (SYBX)111+0.29%53%
DYNATRONICS CORP (DYNT)1100.00%30%
Mirati Therapeutics, Inc. (MRTX)109+0.11%81%

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.